chronic lymphocytic leukemia

Feasibility and efficacy of addition of individualized dose lenalidomide to chlorambucil and rituximab as first-line treatment in elderly and FCR-unfit patients with advanced chronic lymphocytic leukemia
Arnon P. Kater, Marinus H.J. van Oers, Yvette van Norden, Lina van der Straten, Julia Driessen, Ward F.M. Posthuma, Martinus Schipperus, Martine E.D. Chamuleau, Marcel Nijland, Jeanette K. Doorduijn, Michel Van Gelder, Mels Hoogendoorn, Francien De Croon, Shulamiet Wittebol, J. Martijn Kerst, Erik W.A. Marijt, Reinier A.P. Raymakers, Martijn R. Schaafsma, Johan A. Dobber, Sabina A. Kersting, Mark-David Levin, HOVON CLL study group

Haematologica Aug 2018, haematol.2018.193854; DOI: 10.3324/haematol.2018.193854
Inhibition of Btk by Btk-specific concentrations of ibrutinib and acalabrutinib delays but does not block platelet aggregation to GPVI
Phillip L.R. Nicolson, Craig E. Hughes, Stephanie Watson, Sophie H. Nock, Alexander T. Hardy, Callum N. Watson, Samantha J. Montague, Jean-Daniel Malcor, Mark R. Thomas, Alice Y. Pollitt, Michael G. Tomlinson, Guy Pratt, Steve P. Watson

Haematologica Jul 2018, haematol.2018.193391; DOI: 10.3324/haematol.2018.193391
Safety of obinutuzumab alone or combined with chemotherapy for previously untreated or relapsed/refractory chronic lymphocytic leukemia in the Phase 3b GREEN study
Véronique Leblond, Melih Aktan, Christelle M Ferra Coll, Caroline Dartigeas, Jens Kisro, Marco Montillo, João Raposo, Jean-Louis Merot, Susan Robson, Ekaterina Gresko, Francesc Bosch, Stephan Stilgenbauer, Robin Foà

Haematologica Jul 2018, haematol.2017.186387; DOI: 10.3324/haematol.2017.186387
Idelalisib impairs T-cell-mediated immunity in chronic lymphocytic leukemia
Silvia Martinelli, Rossana Maffei, Stefania Fiorcari, Chiara Quadrelli, Patrizia Zucchini, Stefania Benatti, Leonardo Potenza, Mario Luppi, Roberto Marasca

Haematologica Jul 2018, haematol.2017.187070; DOI: 10.3324/haematol.2017.187070
Trisomy 12 chronic lymphocytic leukemia expresses a unique set of activated and targetable pathways
Lynne V. Abruzzo, Carmen D. Herling, George A. Calin, Christopher Oakes, Lynn L. Barron, Haley E. Banks, Vikram Katju, Michael J. Keating, Kevin R. Coombes

Haematologica Jul 2018, haematol.2018.190132; DOI: 10.3324/haematol.2018.190132
Adherence to the Western, Prudent, and Mediterranean dietary patterns and chronic lymphocytic leukemia in the MCC-Spain study.
Marta Solans, Adela Castelló, Yolanda Benavente, Rafael Marcos-Gragera, Pilar Amiano, Esther Gracia-Lavedan, Laura Costas, Claudia Robles, Eva Gonzalez Barca, Esmeralda de la Banda, Esther Alonso, Marta Aymerich, Elias Campo, Trinidad Dierssen-Sotos, Guillermo Fernández-Tardón, Rocio Olmedo-Requena, Eva Gimeno, Gemma Castaño-Vinyals, Nuria Aragonés, Manolis Kogevinas, Silvia de Sanjose, Marina Pollán, Delphine Casabonne

Haematologica Jun 2018, haematol.2018.192526; DOI: 10.3324/haematol.2018.192526
A reversible carnitine palmitoyltransferase I (CPT1) inhibitor offsets chronic lymphocytic leukemia cell proliferation
Elena Gugiatti, Claudya Tenca, Silvia Ravera, Marina Fabbi, Fabio Ghiotto, Andrea N. Mazzarello, Davide Bagnara, Daniele Reverberi, Daniela Zarcone, Giovanna Cutrona, Adalberto Ibatici, Ermanno Ciccone, Zbigniew Darzynkiewicz, Franco Fais, Silvia Bruno

Haematologica Jun 2018, haematol.2017.175414; DOI: 10.3324/haematol.2017.175414
Pre-diagnosis plasma immune markers and risk of non-Hodgkin lymphoma in two prospective cohort studies
Mara M. Epstein, Bernard Rosner, Elizabeth C. Breen, Julie L. Batista, Edward L. Giovannucci, Larry Magpantay, Jon C. Aster, Scott J. Rodig, Kimberly A. Bertrand, Francine Laden, Otoniel Martínez-Maza, Brenda M. Birmann

Haematologica Jun 2018, haematol.2017.183236; DOI: 10.3324/haematol.2017.183236
Real-world treatment and outcomes among older adults with chronic lymphocytic leukemia before the novel agents era
Anthony Mato, Jordan Jahnke, Pengxiang Li, Maneesha Mehra, Vrushabh P. Ladage, Michelle Mahler, Scott Huntington, Jalpa A. Doshi

Haematologica Apr 2018, haematol.2017.185868; DOI: 10.3324/haematol.2017.185868
Innate lymphoid cells are expanded and functionally altered in chronic lymphocytic leukemia
Iris de Weerdt, Vera van Hoeven, J. Marius Munneke, Sanne Endstra, Tom Hofland, Mette D. Hazenberg, Arnon P. Kater

Haematologica Nov 2016, 101 (11) e461-e464; DOI: 10.3324/haematol.2016.144725

chronic lymphocytic leukemia

Pages